Pharmacodynamics, a tool for a better use of antibiotics?

被引：10

作者：

Crokaert, F ^{[1
]}

机构：

[1] Free Univ Brussels, Inst Jules Bordet, Infect Dis Unit, Dept Clin Lab, B-1000 Brussels, Belgium

来源：

INTENSIVE CARE MEDICINE | 2001年 / 27卷 / 02期

关键词：

D O I：

10.1007/s001340100865

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：340 / 343

页数：6

共 21 条

[1] Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia [J].

Caldwell, JW ;

Singh, S ;

Johnson, RH .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 :129-134

[2] Emergence of antibiotic-resistant Pseudomonas aeruginosa:: Comparison of risks associated with different antipseudomonal agents [J].

Carmeli, Y ;

Troillet, N ;

Eliopoulos, GM ;

Samore, MH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1379-1382

[3] Comparisons between antimicrobial pharmacodynamic indices and bacterial killing as described by using the Zhi model [J].

Corvaisier, S ;

Maire, PH ;

d'Yvoire, MYB ;

Barbaut, X ;

Bleyzac, N ;

Jelliffe, RW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) :1731-1737

[4]

Craig W A, 1993, Scand J Infect Dis Suppl, V91, P33

[5] Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].

Craig, WA .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10

[6] EXAMINATION OF GRAM-NEGATIVE BACILLI FROM MENINGITIS PATIENTS WHO FAILED OR RELAPSED ON MOXALACTAM THERAPY [J].

ENG, RHK ;

CHERUBIN, C ;

SMITH, SM ;

BUCCINI, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (06) :850-856

[7] A new approach to in vitro comparisons of antibiotics in dynamic models: Equivalent area under the Curve/MIC breakpoints and equiefficient doses of trovafloxacin and ciprofloxacin against bacteria of similar susceptibilities [J].

Firsov, AA ;

Vostrov, SN ;

Shevchenko, AA ;

Portnoy, YA ;

Zinner, SH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) :2841-2847

[8] Pharmacokinetics of cefpirome during the posttraumatic systemic inflammatory response syndrome [J].

Jacolot, A ;

Incagnoli, P ;

Edouard, AR ;

Tod, M ;

Petitjean, O ;

Samii, K ;

Mimoz, O .

INTENSIVE CARE MEDICINE, 1999, 25 (05) :486-491

[9]

LIPMAN J, 2001, INTENSIVE CARE MED, V27

[10] Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method [J].

Manduru, M ;

Mihm, LB ;

White, RL ;

Friedrich, LV ;

Flume, PA ;

Bosso, JA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2527-2532

← 1 2 3 →